Kapil Bhutada | Senior Director, Safety Operations and Compliance, Medical Safety & Pharmacovigilance
AskBio

Kapil Bhutada, Senior Director, Safety Operations and Compliance, Medical Safety & Pharmacovigilance, AskBio

Kapil Bhutada is a seasoned professional with extensive experience in safety operations and compliance within the pharmaceutical industry. Currently serving as the Head of Safety Operations and Compliance at AskBio, Kapil plays a pivotal role in the Medical Safety & Pharmacovigilance division. With a strong background in pharmacovigilance, risk management, and safety surveillance, he is dedicated to ensuring the highest standards of safety and compliance in drug development and post-market surveillance.

Throughout his career, Kapil has demonstrated a commitment to leveraging innovation and technology to enhance performance and drive efficiency in safety operations. His strategic leadership and expertise have been instrumental in developing and implementing robust safety processes and systems that meet regulatory requirements and industry best practices. Kapil is known for his collaborative approach, working closely with cross-functional teams and external partners to achieve common safety objectives.

At the World Drug Safety Congress Americas 2025, Kapil Bhutada will share his insights and experiences on leveraging innovation, technology, and performance optimization for safety professionals and partners. His presentation promises to offer valuable perspectives on navigating the evolving landscape of drug safety, harnessing the power of technology for enhanced pharmacovigilance, and driving performance excellence in safety operations. Attendees can expect to gain practical strategies and actionable insights from Kapil's expertise in safety operations and compliance within the dynamic pharmaceutical industry.

Appearances:



Day 1 - World Drug Safety Congress Americas 2025 @ 12:20

Presentation: To be announced

Day 1 - World Drug Safety Congress Americas 2025 @ 15:00

Presentation: Long-term Follow-Up and Inspection Readiness for Gene Therapies

last published: 02/Jul/25 19:45 GMT

back to speakers

Get Involved At Drug Safety Congress Americas

 

CONNECT WITH US

 

To Sponsor

Semen Sen
semen.sen@terrapinn.com
t/ + 646-619-1793

 

To Speak

Kaylee Nguyen
kaylee.nguyen@terrapinn.com

 

Marketing & Press

Emily Ngai
emily.ngai@terrapinn.com